Physician

Jeffrey Globerson, DO

According to 2025 Medicare claims, Jeffrey Globerson, DO (NPI: 1447770672) practices dermatology in the Kalamazoo-Portage, MI market, with the plurality of this provider's patient population coming from Kalamazoo, MI. This provider's primary affiliated billing organization is PARAGON HEALTH, P.C. (NPI: 1902847098; TIN: 383309299) and primary practice location at 49024-4883.

Globerson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 449 traditional Medicare patients, billed 2,697 HCPCS/CPT codes, and received $258,074 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 1,373 prescription claims across 596 beneficiaries totaling $581,790 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 94 records totaling $2,164. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $585 to $581,790. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$185K$370K2021 Medicare payment: $144,509 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $224,962 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $369,936 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $258,074 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
20213711,830$144,509
20224812,768$224,962
20235073,569$369,936
20244492,697$258,074

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$291K$582K2017 Drug cost: $585 (USD; Tot_Drug_Cst)2018 Drug cost: $1,450 (USD; Tot_Drug_Cst)2021 Drug cost: $16,686 (USD; Tot_Drug_Cst)2022 Drug cost: $262,661 (USD; Tot_Drug_Cst)2023 Drug cost: $374,416 (USD; Tot_Drug_Cst)2024 Drug cost: $581,790 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/R14$585
20182044$1,450
2019N/RN/RN/R
2020N/RN/RN/R
2021218392$16,686
20224891,052$262,661
20235311,150$374,416
20245961,373$581,790

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks91114$408
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more130156$58
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more9393$52
17000Destruction of precancer skin growth, 1 growth120138$30
17003Destruction of precancer skin growth, 2-14 growths87374$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab401,078$150,209
RinvoqUpadacitinib17510$107,021
FluorouracilFluorouracil902,637$5,297
Betamethasone DipropionateBetamethasone Dipropionate1042,932$4,556
Clobetasol PropionateClobetasol Propionate1083,430$3,761

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.94$2,164ABBVIE INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jeffrey Globerson, DO?

Tedicare shows public-source Medicare data for Jeffrey Globerson, DO (NPI 1447770672), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey Globerson, DO have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jeffrey Globerson, DO?

Jeffrey Globerson, DO is linked to PARAGON HEALTH, P.C. (billing NPI 1902847098) in the available physician profile data.

Does Jeffrey Globerson, DO have Open Payments data?

Jeffrey Globerson, DO has 94 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.